Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies998
BioIntervene
BioIntervene is a preclinical-stage biopharmaceutical company that focuses on drug discovery and development.
Sector
Subsector
Keywords
Location
total rounds
total raised
Tigris Pharmaceuticals
Tigris Pharmaceuticals develops therapeutic technologies for oncology and other medical needs.
Sector
Subsector
Location
total rounds
total raised
Hengrui Therapeutics
HTI is a U.S. biopharmaceutical company focused on developing innovative drugs for oncology and endocrinology.
Sector
Subsector
Location
total rounds
total raised
Akeso Biopharma
Akeso Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for oncology and immunology.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds4
Number of Funding Rounds
Money Raised
Their latest funding was raised on 20.11.2020. Their latest investor GIC. Their latest round Post-IPO Equity
Fidelity Management and Research Company
Fidelity Management and Research Company is a private investment manager that aims to make financial expertise accessible to everyone.
Sector
Subsector
Location
count Of Investments
count Of Exists
Boyu Capital
Boyu Capital is a China-focused private equity firm investing in consumer, retail, media, technology, healthcare, and financial services.
Sector
Subsector
Location
count Of Investments
FountainVest Partners
FountainVest is a private equity firm that invests in Chinese industry leaders and emerging leaders.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors15
Number of lead investors
Number of investors
GIC
GIC is a global investment firm managing Singapore's foreign reserves.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
FountainVest Partners
FountainVest is a private equity firm that invests in Chinese industry leaders and emerging leaders.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Fidelity
Fidelity is a privately-owned investment manager that offers a wide range of financial services.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists
People
Founders1
Jay Mei
Jay Mei is the founder, chairman and CEO of Antengene. Prior to founding the company, Dr. Mei has more than twenty years of cancer research and drug development experience, and worked at the US National Cancer Institute (NCI) as well as several multi-national pharmaceutical companies, including Johnson & Johnson Pharmaceutical R&D (J&JPRD), Novartis Oncology and Celgene Corporation. As an Executive Director of Clinical Development at Celgene Corporation, Dr. Mei successfully led the development of REVLIMID® (lenalidomide) in China. REVLIMID® received CFDA approval and was launched in China in 2013. Outside the China market, Dr. Mei was responsible for the clinical trials of REVLIMID® in more than 30 countries. He was also the clinical lead at Celgene on IDHIFA® (enasidenib) which received the FDA approval for relapsed or refractory AML. Before joining Celgene in 2008, Dr. Mei served in multiple clinical development roles at J&JPRD and Novartis Oncology. Prior to industry, Dr. Mei spent eight years on cancer and clinical research at the NCI. Over more than twenty years of his career in academia and industry, Dr. Mei has been an author on over 70 publications and holds multiple patents.
current job
organization founded
Jay Mei
Employee Profiles3
Activity
Recent News15
The graph reveals the ratio (%) of positive news articles in a chosen time range